Literature DB >> 17622599

Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials.

Patrick H Conway1, Avital Cnaan, Theoklis Zaoutis, Brandon V Henry, Robert W Grundmeier, Ron Keren.   

Abstract

CONTEXT: The evidence regarding risk factors for recurrent urinary tract infection (UTI) and the risks and benefits of antimicrobial prophylaxis in children is scant.
OBJECTIVES: To identify risk factors for recurrent UTI in a pediatric primary care cohort, to determine the association between antimicrobial prophylaxis and recurrent UTI, and to identify the risk factors for resistance among recurrent UTIs. DESIGN, PATIENTS, AND
SETTING: From a network of 27 primary care pediatric practices in urban, suburban, and semirural areas spanning 3 states, a cohort of children aged 6 years or younger who were diagnosed with first UTI between July 1, 2001, and May 31, 2006, was assembled. Time-to-event analysis was used to determine risk factors for recurrent UTI and the association between antimicrobial prophylaxis and recurrent UTI, and a nested case-control study was performed among children with recurrent UTI to identify risk factors for resistant infections. MAIN OUTCOME MEASURES: Time to recurrent UTI and antimicrobial resistance of recurrent UTI pathogens.
RESULTS: Among 74 974 children in the network, 611 (0.007 per person-year) had a first UTI and 83 (0.12 per person-year after first UTI) had a recurrent UTI. In multivariable Cox time-to-event models, factors associated with increased risk of recurrent UTI included white race (0.17 per person-year; hazard ratio [HR], 1.97; 95% confidence interval [CI], 1.22-3.16), age 3 to 4 years (0.22 per person-year; HR, 2.75; 95% CI, 1.37-5.51), age 4 to 5 years (0.19 per person-year; HR, 2.47; 95% CI, 1.19-5.12), and grade 4 to 5 vesicoureteral reflux (0.60 per person-year; HR, 4.38; 95% CI, 1.26-15.29). Sex and grade 1 to 3 vesicoureteral reflux were not associated with risk of recurrence. Antimicrobial prophylaxis was not associated with decreased risk of recurrent UTI (HR, 1.01; 95% CI, 0.50-2.02), even after adjusting for propensity to receive prophylaxis, but was a risk factor for antibimicrobial resistance among children with recurrent UTI (HR, 7.50; 95% CI, 1.60-35.17).
CONCLUSION: Among the children in this study, antimicrobial prophylaxis was not associated with decreased risk of recurrent UTI, but was associated with increased risk of resistant infections.

Entities:  

Mesh:

Year:  2007        PMID: 17622599     DOI: 10.1001/jama.298.2.179

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  107 in total

Review 1.  Vesicoureteral reflux: From prophylaxis to surgery.

Authors:  Anne-Sophie Blais; Stéphane Bolduc; Katherine Moore
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  Learning from history or the rationale for considering surgical correction of vesicoureteral reflux.

Authors:  Jonathan Riddell; Julie Franc-Guimond
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

4.  Medical versus surgical management for vesicoureteric reflux: the case for medical management.

Authors:  Armando J Lorenzo
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

Review 5.  Antibiotic resistance in pediatric urology.

Authors:  Rachel S Edlin; Hillary L Copp
Journal:  Ther Adv Urol       Date:  2014-04

6.  The predictive utility of prior positive urine culture in children with recurrent urinary tract infections.

Authors:  Reut Doyev; Efrat Ben-Shalom; Orli Megged
Journal:  Eur J Pediatr       Date:  2019-11-26       Impact factor: 3.183

7.  Escherichia coli biofilm formation and recurrences of urinary tract infections in children.

Authors:  T Tapiainen; A-M Hanni; J Salo; I Ikäheimo; M Uhari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-02       Impact factor: 3.267

8.  Management of urinary tract infection in children.

Authors:  Alan R Watson
Journal:  BMJ       Date:  2007-08-25

9.  Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children.

Authors:  Luciana Robino; Paola Scavone; Lucia Araujo; Gabriela Algorta; Pablo Zunino; María Catalina Pírez; Rafael Vignoli
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

10.  Isolation of Klebsiella pneumoniae producing NDM-1 metallo-β-lactamase from the urine of an outpatient baby boy receiving antibiotic prophylaxis.

Authors:  Veljko Mirovic; Branka Tomanovic; Zorica Lepsanovic; Branko Jovcic; Milan Kojic
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.